Seong Bok Jang

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 3

Top Topics

Epidermal Growth Factor Receptor

Placebo Controlled

Small Cell Lung Cancer

Top Venues

CPT: pharmacometrics & systems pharmacology

Translational and clinical pharmacology

Advances in therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Tae Kyu Chung, Hyun A Lee, Kyeong-Ryoon Lee, Seong Bok Jang, Kyung-Sang Yu, Howard Lee
A population PK-PD model of YH4808, a novel P-CAB, and intragastric pH that incorporated negative feedback by increased intragastric pH onto the systemic exposure to YH4808. CPT: pharmacometrics & systems pharmacology 11 (9) (2022)
Bomin Kim, Jungwook Lee, Hyunwoo Jang, Nami Lee, Jaydeep Mehta, Seong Bok Jang
Effects of Acid-Reducing Agents on the Pharmacokinetics of Lazertinib in Patients with EGFR Mutation-Positive Advanced Non-Small-Cell Lung Cancer. Advances in therapy 39 (10) (2022)
Sukyong Yoon, EunSil Oh, Min Soo Park, Seong Bok Jang, Hae Mi Byun, Hyeonsoo Park, Heeyoung Kim, Choon-Ok Kim
Comparison of the pharmacokinetics and pharmacodynamics of YH4808 in healthy subjects for defining an appropriate dosing regimen. Translational and clinical pharmacology 29 (3) (2021)